Abstract Pentraxin 3 (PTX3) is an acute-phase protein that was recently demonstrated to
play pleiotropic activities in cardiovascular (CV) diseases. Tumor necrosis factor and …

Obesity is defined as the excess accumulation of intra‐abdominal body fat, resulting in a
state of chronic, low‐grade proinflammation that can directly contribute to the development …

The circulatory level of pentraxin 3 (PTX3), an anti-inflammatory cardioprotective protein,
has been shown to be lower in obese individuals than in those with normal weight …

Background & objectives: Non-alcoholic fatty liver disease (NAFLD) is the most common
chronic liver disease in the world which is associated with cardiovascular disease. The aim …

Objective: The relationship between overweightness, obesity and arterial stiffness remains
unclear. We performed a meta-analysis evaluating the impact of obesity/overweightness on …

Follicular development is a highly coordinated process that in humans takes more than 6
months. Pituitary gonadotropins and a variety of locally produced growth factors and …

Objective The relation between inflammatory markers, adiposity and disease is under
extensive study. Here we tested the hypothesis that the immunomodulatory protein pentraxin …

Cardiorespiratory fitness is negatively associated with arterial stiffness, although it is unclear
whether it is associated with prospective arterial stiffness changes. The authors examined …

There is a delayed increase in arterial stiffness after eccentric exercise that is possibly
mediated by the concurrent delayed increase in circulating oxidative stress. Taurine has anti …

Objective. The aim of the present study was to investigate whether pentraxin 3 (PTX3) can
be a new noninvasive marker for prediction of liver fibrosis in patients with NAFLD. We also …